EMA seeks executive director

Andreas Pott will be acting executive director until position is filled

The European Medicines Agency (EMA) is seeking a new executive director. Its current head, Thomas Lönngren, is leaving the post on 31 December, following the end of his second five-year mandate.

While EMA searches for a permanent replacement, its current head of administration, Andreas Pott, will serve as acting executive director.

University of Hamburg graduate, Pott has been the agency’s administration chief since 2000, having previously worked for the European Parliament and the EU’s translation service.

Swede Lönngren is a former deputy director-general of the Swedish Medical Products Agency (MPA).

You may also like

Manufacturing

Sapio Sciences and Ultima Genomics to work together in advancing multiomics research

The partnership delivers global, end-to-end solutions aimed at making genomics research more streamlined and accessible
Cell & Gene Therapy

Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development

Collaboration will accelerate stable cell line development in AAV genomic medicine development and ultimately also shorten the development timeline to clinic
Manufacturing

Watson-Marlow to showcase new Bredel CIP pump and innovative fluid handling solutions at PPMA

Watson-Marlow Fluid Technology Solutions (WMFTS) will unveil the new Bredel CIP pump as well as highlight its advanced fluid management technologies during PPMA at the NEC in Birmingham, UK, from 23-25 September 2025
Manufacturing

Evonik and Ethris partner to develop novel lipid nanoparticle platform for nucleic acid delivery

The partnership will enable Evonik to bring more stable and targeted nucleic acid therapies and vaccines to market
Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
Manufacturing

LGC Group opens $100m Organic Chemistry Synthesis Centre of Excellence in Ontario

The new facility in Vaughn is one of the largest of its kind in the world and will ship to more than 170 countries
Manufacturing

IMA Active to showcase its new tablet presses at NEXTEN in Italy

The event, set at Villa Erba, will celebrate tableting innovation and involve leaders in the pharmaceutical industry through a variety of technical sessions
Subscribe now